摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Potassium calcium citrate

中文名称
——
中文别名
——
英文名称
Potassium calcium citrate
英文别名
calcium;potassium;2-hydroxypropane-1,2,3-tricarboxylate
Potassium calcium citrate化学式
CAS
——
化学式
C6H5CaKO7
mdl
——
分子量
268.28
InChiKey
SPGDAODMONVAAC-UHFFFAOYSA-K
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -8.63
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    141
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • Dual Cation Dual Anion Coordination Complexes
    申请人:Walter Mary Ann
    公开号:US20100184866A1
    公开(公告)日:2010-07-22
    Compounds are provided herein which are coordination complexes of the formula, A x B y Cit 2 F z .mH 2 O, wherein A is a cation selected from certain IA or IIA metal ions in the Periodic Table; B is a cation selected from certain IIA metal ions and certain divalent d-block transition metal ions; A and B are different; “Cit” is tribasic citric acid anion; the stoichiometric ratio of x to y is equal or higher than 1.0 but lower than 8.0; m is 0-12; and z is selected such that electroneutrality is preserved. Compounds provided herein are useful to treat dietary deficiencies, osteoporosis, osteopenia, bone loss, and risk of bone loss, as well as other medical conditions involving the need for administration of the various ions. In addition, the compounds can be used as fluoride sources for dental use and to fluoridate water systems.
    本文提供的化合物是配位化合物,化学式为AxByCit2Fz.mH2O,其中A是周期表中某些IA或IIA属离子中选择的阳离子;B是从某些IIA属离子和某些二价d-块过渡属离子中选择的阳离子;A和B是不同的;“Cit”是三碱性柠檬酸根离子;x到y的化学计量比大于或等于1.0但小于8.0;m为0-12;z被选择以保持电中性。本文提供的化合物可用于治疗膳食缺乏、骨质疏松症、骨质疏松症、骨质流失以及骨质流失风险,以及其他需要给予各种离子的医疗情况。此外,这些化合物可用作牙科用化物来源,用于系统。
  • Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
    申请人:Pak Charles Y.C.
    公开号:US20070077314A1
    公开(公告)日:2007-04-05
    A composition comprising a powder mixture of potassium citrate and calcium citrate as mixtures of pure chemical salts and methods of making and using the composition are disclosed. The composition is useful for the treatment and prevention of kidney stones and osteoporosis and better delivers potassium and calcium than commonly used potassium and calcium supplements.
    本发明揭示了一种包含柠檬酸柠檬酸钙的粉末混合物的组合物,这些混合物是纯化学盐的混合物,并揭示了制备和使用该组合物的方法。该组合物对于肾结石和骨质疏松症的治疗和预防非常有用,并且比常用的补充剂更好地提供
  • POWDER MIX OF POTASSIUM CALCIUM CITRATE FOR THE TREATMENT OF KIDNEY STONES AND OSTEOPOROSIS
    申请人:Pak Charles Y. C.
    公开号:US20100227006A1
    公开(公告)日:2010-09-09
    A composition comprising a powder mixture of potassium citrate and calcium citrate as mixtures of pure chemical salts and methods of making and using the composition are disclosed. The composition is useful for the treatment and prevention of kidney stones and osteoporosis and better delivers potassium and calcium than commonly used potassium and calcium supplements.
    本发明揭示了一种由柠檬酸柠檬酸钙的粉末混合物组成的配方,这些混合物是纯化学盐的混合物,以及制备和使用该配方的方法。该配方可用于治疗和预防肾结石和骨质疏松症,并且比通常使用的补充剂更好地提供
  • Process for the fortification of a fruit based food product with calcium
    申请人:Purac Biochem B.V.
    公开号:EP1295536A1
    公开(公告)日:2003-03-26
    The present invention relates to a process for the fortification of food products containing fruit, such as fruit juices, concentrates, syrups or spreads with calcium. According to this process an inorganic calcium salt and a calcium salt of an organic acid are added to the fruit containing food product. In particular this method is suitable for food products with fruit containing anthocyanins, such as cranberries. A preferred combination of calcium salts is a calcium salt of lactic acid with calcium chloride.
    本发明涉及一种对含果的食品,如果汁、浓缩果汁、糖浆或涂抹酱进行强化的工艺。根据该工艺,无机盐和有机酸盐被添加到含果的食品中。这种方法尤其适用于含有花青素果食品,如蔓越莓。盐的首选组合是乳酸钙盐和氯化钙
  • Liquid dietary supplement formulation compositions
    申请人:Watermins LLC
    公开号:US10251412B2
    公开(公告)日:2019-04-09
    This invention relates to liquid dietary supplement formulation compositions that provide dietary minerals and additional optional ingredients beneficial for health; methods of design and manufacture of such compositions; and methods to enable convenient oral ingestion of the formulation ingredients, by adding the formulations to drinking water, beverages, foods, or meals. The formulation compositions of this invention generally include water, water-soluble calcium compound(s), water-soluble magnesium compound(s), and additional optional ingredients, wherein the sum of the concentrations of the calcium and magnesium compounds is most preferably 2 molar or more, up to the point of saturation. The formulations of this invention possess inherent resistance to microbial growth. The formulations of this invention and variations thereof can be used as dietary supplements to increase intake of beneficial minerals, to mineralize water, to fortify foods or beverages, and can also be used to prepare a variety of additional liquid formulations by varying the calcium and magnesium compounds, and/or by adding one or more compatible ingredient(s).
    本发明涉及提供有益于健康的膳食矿物质和其他可选成分的液态膳食补充剂配方组合物;设计和制造这种组合物的方法;以及通过将配方添加到饮用、饮料、食品或膳食中,方便口服配方成分的方法。本发明的配方组合物一般包括溶性化合物、溶性化合物和其他可选成分,其中化合物的浓度之和最好为 2 摩尔或更高,直至饱和点。本发明的配方具有抗微生物生长的固有特性。本发明的制剂及其变体可用作膳食补充剂,以增加有益矿物质的摄入量,使矿化,强化食品或饮料,也可通过改变化合物和/或添加一种或多种兼容成分来制备各种其他液体制剂。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸